FindTrial
Sign In

Effect of Lymph Node Examined Count on Accurate Staging and Survival of Resected Esophageal Cancer

Effect of Lymph Node Examined Count on Accurate Staging and Survival of Resected Esophageal Cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800018237
Enrollment
Unknown
Registered
2018-09-06
Start date
2018-09-30
Completion date
Unknown
Last updated
2018-09-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

esophageal cancer

Interventions

Case series:Not applied

Sponsors

Nanjing Medical University Affiliated Cancer Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 75 Years

Inclusion criteria

Inclusion criteria: (1) Aged 18-80 years old; (2) preoperative ZPS = 2 points and Karnofsky score = 70 points; (3) oesophageal cancer diagnosed by preoperative ultrasound gastroscopy, chest CT, esophageal MRI and other examinations; (4) good cardiopulmonary function evaluated to tolerate surgery; (5) patients who sign the informed consent.

Exclusion criteria

Exclusion criteria: (1) Preoperative examination show that the tumor has invaded surrounding tissues, lymph nodes and important organ metastases; (2) History of previous cervicothoracic and abdominal surgery; (3) Patients who refuse to sign the informed consent.

Design outcomes

Primary

MeasureTime frame
Overall Survival;—

Countries

China

Contacts

Public ContactLin Xu

Nanjing Medical University Affiliated Cancer Hospital

hyzx301xwj@gmail.com+86 18205087180

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026